newsmetry
rusign inget started
macro

BMO Capital Raises NiSource Price Target to $48 From $45

BMO Capital lifted its NiSource price target to $48 a share from $45 and kept an Outperform rating, Dow Jones Newswires reports.

published on Newsmetry
original source published

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

Newsmetry newsroom

what happened

According to Dow Jones Newswires, citing Benzinga, BMO Capital raised its price target on NiSource shares to $48 a share from $45. The brokerage maintained its Outperform rating on the stock.

Updates of this kind are a routine part of analyst coverage and come without any new financial data from the company.

why it matters

A single bank's target change usually affects sentiment around the stock only. For the US utilities sector, such revisions rarely move the broader market.

market impact

Акции NiSource: повышенная целевая цена отражает более позитивный взгляд одного аналитика

tags

Analyst RatingStockUnited States

instruments

NI

sources

  1. NiSource Price Target Raised to $48.00/Share From $45.00 by BMO Capital — Dow Jones Newswires, 19 October 2026 at 17:41 UTC
  2. CenterPoint Energy Price Target Cut to $45.00/Share From $48.00 by BMO Capital — Dow Jones Newswires, 19 October 2026 at 17:50 UTC
  3. Disc Medicine Price Target Raised to $120.00/Share From $100.00 by BMO Capital — Dow Jones Newswires, 19 October 2026 at 18:01 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗

related stories